Child and Adolescent Depression Intervention Overview: What Works, for Whom and How Well?

Child and Adolescent Psychiatric Clinics of North America

Volumn 21, Issue 2, 2012, Pages 299-312

  Maalouf, Fadi T ^a,b   Brent, David A ^c  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescents; Children; Depression; Psychotherapy; Selective serotonin reuptake inhibitors

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOMIPRAMINE; DIPHENHYDRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; LIOTHYRONINE; LITHIUM; MIRTAZAPINE; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ZOLPIDEM;

ADOLESCENT; ANHEDONIA; ANXIETY DISORDER; CASE MANAGEMENT; CHILD; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTHYMIA; ENVIRONMENTAL FACTOR; FAMILY CONFLICT; FAMILY STRESS; FATIGUE; HUMAN; INTERPERSONAL PSYCHOTHERAPY; IRRITABILITY; MAJOR DEPRESSION; MANIA; METABOLIC SYNDROME X; OBESITY; OBSESSIVE COMPULSIVE DISORDER; PATIENT EDUCATION; POLYPHARMACY; PRIORITY JOURNAL; PSYCHOTHERAPY; RECURRENCE RISK; REMISSION; REVIEW; SCHOOL STRESS; SIDE EFFECT; SLEEP DISORDER; SOCIAL SUPPORT; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; INTERPERSONAL RELATIONS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SLEEP DISORDERS; SUICIDAL IDEATION; SUICIDE; TREATMENT OUTCOME;

EID: 84860299421     PISSN: 10564993     EISSN: 15580490     Source Type: Journal    
DOI: 10.1016/j.chc.2012.01.001     Document Type: Review

References (84)

1. Birmaher B., Brent D., Bernet W., et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007, 46(11):1503-1526.
2. Brent D.A., Holder D., Kolko D., et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 1997, 54(9):877-885.
3. Birmaher B., Brent D.A., Kolko D., et al. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 2000, 57(1):29-36.
4. Wood A., Harrington R., Moore A. Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry 1996, 37(6):737-746.
5. Weisz J.R., Southam-Gerow M.A., Gordis E.B., et al. Cognitive-behavioral therapy versus usual clinical care for youth depression: an initial test of transportability to community clinics and clinicians. J Consult Clin Psychol 2009, 77(3):383-396.
6. Harrington R., Campbell F., Shoebridge P., et al. Meta-analysis of CBT for depression in adolescents. J Am Acad Child Adolesc Psychiatry 1998, 37(10):1005-1007.
7. Weisz J.R., McCarty C.A., Valeri S.M. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006, 132(1):132-149.
8. March J., Silva S., Petrycki S., et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004, 292(7):807-820.
9. Kennard B., Silva S., Vitiello B., et al. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006, 45(12):1404-1411.
10. Curry J., Rohde P., Simons A., et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006, 45(12):1427-1439.
11. Asarnow J.R., Emslie G., Clarke G., et al. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry 2009, 48(3):330-339.
12. Feeny N.C., Silva S.G., Reinecke M.A., et al. An exploratory analysis of the impact of family functioning on treatment for depression in adolescents. J Clin Child Adolesc Psychol 2009, 38(6):814-825.
13. Brent D.A., Kolko D.J., Birmaher B., et al. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry 1998, 37(9):906-914.
14. Barbe R.P., Bridge J.A., Birmaher B., et al. Lifetime history of sexual abuse, clinical presentation, and outcome in a clinical trial for adolescent depression. J Clin Psychiatry 2004, 65(1):77-83.
15. Shamseddeen W., Asarnow J.R., Clarke G., et al. Impact of Physical and Sexual Abuse on Treatment Response in the Treatment of Resistant Depression in Adolescent Study (TORDIA). J Am Acad Child Adolesc Psychiatry 2011, 50(3):293-301.
16. Emslie G., Kratochvil C., Vitiello B., et al. Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry 2006, 45(12):1440-1455.
17. Brent D.A., Emslie G.J., Clarke G.N., et al. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry 2009, 166(4):418-426.
18. Goodyer I., Dubicka B., Wilkinson P., et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ 2007, 335(7611):142.
19. Garber J., Clarke G.N., Weersing V.R., et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA 2009, 301(21):2215-2224.
20. Clarke G.N., Hornbrook M., Lynch F., et al. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry 2001, 58(12):1127-1134.
21. Kroll L., Harrington R., Jayson D., et al. Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry 1996, 35(9):1156-1161.
22. Kennard B.D., Emslie G.J., Mayes T.L., et al. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry 2008, 47(12):1395-1404.
23. Klomek A.B., Mufson L. Interpersonal psychotherapy for depressed adolescents. Child Adolesc Psychiatr Clin N Am 2006, 15(4):959-975. ix.
24. Rossello J., Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol 1999, 67(5):734-745.
25. Rossello J., Bernal G., Rivera-Medina C. Individual and group CBT and IPT for Puerto Rican adolescents with depressive symptoms. Cultur Divers Ethnic Minor Psychol 2008, 14(3):234-245.
26. Mufson L., Dorta K.P., Wickramaratne P., et al. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 2004, 61(6):577-584.
27. Horowitz J.L., Garber J., Ciesla J.A., et al. Prevention of depressive symptoms in adolescents: a randomized trial of cognitive-behavioral and interpersonal prevention programs. J Consult Clin Psychol 2007, 75(5):693-706.
28. Walkup J.T., Albano A.M., Piacentini J., et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008, 359(26):2753-2766.
29. Bridge J.A., Iyengar S., Salary C.B., et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007, 297(15):1683-1696.
30. Apter A., Lipschitz A., Fong R., et al. Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine. J Child Adolesc Psychopharmacol 2006, 16(1/2):77-90.
31. Cheung A.H., Emslie G.J., Mayes T.L. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 2005, 46(7):735-754.
32. Findling R.L., McNamara N.K., Stansbrey R.J., et al. The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression. J Child Adolesc Psychopharmacol 2006, 16(1/2):131-145.
33. Bridge J.A., Birmaher B., Iyengar S., et al. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 2009, 166(1):42-49.
34. Brent D., Emslie G., Clarke G., et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008, 299(8):901-913.
35. Emslie G.J., Findling R.L., Yeung P.P., et al. Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 2007, 46(4):479-488.
36. Emslie G.J., Mayes T., Porta G., et al. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. Am J Psychiatry 2010, 167(7):782-791.
37. Hazell P., O'Connell D., Heathcote D., et al. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 2002, 2. CD002317.
38. DeVeaugh-Geiss J., Moroz G., Biederman J., et al. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder-a multicenter trial. J Am Acad Child Adolesc Psychiatry 1992, 31(1):45-49.
39. Sallee F.R., Vrindavanam N.S., Deas-Nesmith D., et al. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am J Psychiatry 1997, 154(5):668-673.
40. Glod C.A., Lynch A., Flynn E., et al. Open trial of bupropion SR in adolescent major depression. J Child Adolesc Psychiatr Nurs 2003, 16(3):123-130.
41. Daviss W.B., Bentivoglio P., Racusin R., et al. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry 2001, 40(3):307-314.
42. March J, Graham E, Kratochvil C, et al. An open-label study of tolerability, safety, and pharmacokinetics of duloxetine in children (7-11 years) and adolescents (12-17 years) with MDD. Presented at the 49th annual New Clinical Drug Evaluation Unit (NCDEU) Meeting. Hollywood, Florida, June 29 to July 2, 2009.
43. Daviss W.B., Perel J.M., Brent D.A., et al. Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study. Ther Drug Monit 2006, 28(2):190-198.
44. Emslie G.J., Rush A.J., Weinberg W.A., et al. Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depress Anxiety 1998, 7(1):32-39.
45. Sakolsky D.J., Perel J.M., Emslie G.J., et al. Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study. J Clin Psychopharmacol 2011, 31(1):92-97.
46. Heiligenstein J.H., Hoog S.L., Wagner K.D., et al. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study. J Child Adolesc Psychopharmacol 2006, 16(1/2):207-217.
47. Woldu H., Porta G., Goldstein T., et al. Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial. J Am Acad Child Adolesc Psychiatry 2011, 50(5):490-498.
48. Nakonezny P.A., Hughes C.W., Mayes T.L., et al. A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine. J Child Adolesc Psychopharmacol 2010, 20(5):431-439.
49. Brent D., Melhem N., Turecki G. Pharmacogenomics of suicidal events. Pharmacogenomics 2010, 11(6):793-807.
50. Vitiello B., Silva S.G., Rohde P., et al. Suicidal events in the Treatment for Adolescents With Depression Study (TADS). J Clin Psychiatry 2009, 70(5):741-747.
51. Vitiello B., Emslie G., Clarke G., et al. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry 2010, 72(3):388-396.
52. March J.S., Silva S., Petrycki S., et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007, 64(10):1132-1143.
53. Wilkinson P., Kelvin R., Roberts C., et al. Clinical and psychosocial predictors of suicide attempts and nonsuicidal self-injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT). Am J Psychiatry 2011, 168(5):495-501.
54. Vitiello B., Rohde P., Silva S., et al. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006, 45(12):1419-1426.
55. Dubicka B., Elvins R., Roberts C., et al. Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis. Br J Psychiatry 2010, 197:433-440.
56. Lewis C.C., Simons A.D., Nguyen L.J., et al. Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2010, 49(2):132-140.
57. Maalouf F.T., Porta G., Vitiello B., et al. Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents?. A latent class analysis from the TORDIA study. J Affect Disord 2012 Jan 26, [epub ahead of print].
58. Tao R., Emslie G., Mayes T., et al. Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. J Am Acad Child Adolesc Psychiatry 2009, 48(1):71-78.
59. Blier P., Ward H.E., Tremblay P., et al. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. Am J Psychiatry 2010, 167(3):281-288.
60. Cooper-Kazaz R., Apter J.T., Cohen R., et al. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2007, 64(6):679-688.
61. Diazgranados N., Ibrahim L., Brutsche N.E., et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010, 67(8):793-802.
62. Rush A.J., Trivedi M.H., Stewart J.W., et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011, 168(7):689-701.
63. Nelson J.C., Papakostas G.I. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 2009, 166(9):980-991.
64. Rush A.J., Warden D., Wisniewski S.R., et al. STAR*D: revising conventional wisdom. CNS Drugs 2009, 23(8):627-647.
65. Pathak S., Johns E.S., Kowatch R.A. Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series. J Child Adolesc Psychopharmacol 2005, 15(4):696-702.
66. Correll C.U., Manu P., Olshanskiy V., et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009, 302(16):1765-1773.
67. Kennard B.D., Silva S.G., Tonev S., et al. Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry 2009, 48(2):186-195.
68. March J., Silva S., Curry J., et al. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry 2009, 166(10):1141-1149.
69. Curry J., Silva S., Rohde P., et al. Recovery and recurrence following treatment for adolescent major depression. Arch Gen Psychiatry 2011, 68(3):263-269.
70. Thase M.E., Fasiczka A.L., Berman S.R., et al. Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Arch Gen Psychiatry 1998, 55(2):138-144.
71. Roane B.M., Taylor D.J. Adolescent insomnia as a risk factor for early adult depression and substance abuse. Sleep 2008, 31(10):1351-1356.
72. Tao R., Emslie G.J., Mayes T.L., et al. Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder. J Child Adolesc Psychopharmacol 2010, 20(5):423-430.
73. Goldstein T.R., Bridge J.A., Brent D.A. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol 2008, 76(1):84-91.
74. Shamseddeen W., Clarke G., DeBar L., et al. Insomnia medications and outcomes in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study. J Child Adolesc Psychopharmacol 2012, [Epub ahead of print].
75. Manber R., Edinger J.D., Gress J.L., et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008, 31(4):489-495.
76. Weissman M.M., Pilowsky D.J., Wickramaratne P.J., et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA 2006, 295(12):1389-1398.
77. Eltz M.J., Shirk S.R., Sarlin N. Alliance formation and treatment outcome among maltreated adolescents. Child Abuse Negl 1995, 19(4):419-431.
78. Swartz H.A., Frank E., Zuckoff A., et al. Brief interpersonal psychotherapy for depressed mothers whose children are receiving psychiatric treatment. Am J Psychiatry 2008, 165(9):1155-1162.
79. Correa R., Akiskal H., Gilmer W., et al. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?. J Affect Disord 2010, 127(1-3):10-18.
80. Axelson D.A., Perel J.M., Birmaher B., et al. Sertraline pharmacokinetics and dynamics in adolescents. J Am Acad Child Adolesc Psychiatry 2002, 41(9):1037-1044.
81. Martin A., Young C., Leckman J.F., et al. Age effects on antidepressant-induced manic conversion. Arch Pediatr Adolesc Med 2004, 158(8):773-780.
82. De Cuyper S., Timbremont B., Braet C., et al. Treating depressive symptoms in schoolchildren: a pilot study. Eur Child Adolesc Psychiatry 2004, 13(2):105-114.
83. Weisz J.R., Thurber C.A., Sweeney L., et al. Brief treatment of mild-to-moderate child depression using primary and secondary control enhancement training. J Consult Clin Psychol 1997, 65(4):703-707.
84. Dietz L.J., Mufson L., Irvine H., et al. Family-based interpersonal psychotherapy for depressed preadolescents: an open-treatment trial. Early intervention in psychiatry 2008, 2(3):154-161.